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Three different formulations (infusion, pills and syrup) of Cochlospermum angolensis 
were characterized by HPLC-DAD-ESI/MS regarding phenolic composition, and 
evaluated by their in vitro antimicrobial activity against clinical isolates of 
multiresistant bacteria. Infusion and pills showed the highest variety of phenolic 
compounds, with eleven molecules identified. Protocatechuic acid was only present in 
infusions, being the most abundant compound, while (epi)gallocatechin-O-gallate was 
the main molecule identified in pills and eucaglobulin/globulusin in syrup. Infusion 
revealed antimicrobial activity against all the studied bacteria with the exception of 
Proteus mirabilis whereas the pills revealed activity in Escherichia coli spectrum 
extended producer of β-lactamases and methicillin-resistant Staphylococcus aureus. In 
the syrup there was no antimicrobial activity detected, which is in agreement with its 
low concentrations of phenolic compounds. None of the formulations inhibited P. 
mirabilis. Considering the obtained results, C. angolensis infusion can be considered a 
good source of phenolic compounds as well as a good antimicrobial agent. 
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Plants of the family Cochlospermaceae are widely used in Angola by the native healers 
for the treatment and prevention of liver diseases. Cochlospermum is a genus of tropical 
trees belonging to this family that comprises eleven species occurring in pantropical 
regions (Poppendieck, 1981). Plants of this genus have been reported by their extensive 
use in the treatment of malaria, jaundice and liver injuries, including Cochlospermum 
regium, Cochlospermum tinctorium, Cochlospermum planchonii, and Cochlospermum 
angolensis (Poppendieck, 1981).  
The infusion of C. regium roots has been used to treat intestinal, ovarian and uterine 
inflammation, dermatitis (Pio Corrêa, 1975), ulcers and rheumatoid arthritis (Lewis and 
Hanson, 1991; Ritto, 1996), being also reported the antimicrobial activity of its 
hydroethanolic extract and fractions against Staphylococcus aureus and Pseudomonas 
aeruginosa (Solon et al., 2012). The total aqueous extract of C. tinctorium demonstrated 
potent antiplasmodial activity (Traoré et al., 2006) and its rhizomes extract revealed 
hepatoprotective activity in aflatoxin B1 (Dalvi and Sere, 1988) and carbon 
tetrachloride (CC14) treated rats, and in primary rat hepatocyte cultures exposed to 
cytotoxic concentrations of galactosamine or CC14 (Diallo and Vanhaelen, 1987). A 
crude aqueous extract of C. planchonii showed the capacity to lower serum bilirubin 
levels in rats treated with CC14 and inhibited two cytochrome P-450 enzymes, 
aminopyrine-N-demethylase and aniline hydroxylase (Aliyu et al., 1995). 
Cochlospermum angolense roots infusion inhibited Plasmodium falciparum and 
depressed the DNA synthesis of mice erythrocytes infected by Plasmodium berghei 
(Presber et al., 1992); its bark infusion, pills, and syrup revealed strong antioxidant 
activity, with the infusion also demonstrating anti-hepatocellular carcinoma activity, in 
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previous studies performed by our research group (Pereira et al., 2013; Pereira et al., 
2014).  
According to some reports, the therapeutic purposes of Cochlospermum genus species 
(mainly hepatoprotective effects) can be explained by the presence of phytochemicals, 
specially phenolic an polyphenolic compounds, with gallic and ellagic acids and its 
derivatives as the major compounds (Diallo and Vanhaelen, 1987; Diallo et al., 1992; 
Solon et al., 2012; Ferreres et al., 2013). In particular, C. tinctorium revealed gallic and 
ellagic acids, ellegitannins and flavonoids (Diallo and Vanhaelen, 1987; Diallo et al., 
1992), while C. regium showed ellagic and gallic acids, dihydrokaempferol, 
dihydrokaempferol-3-O-β-glucopyranoside, dihydrokaempferol-3-O-b-(6''-galloyl)-
glucopyranoside, pinoresinol, excelsin  and two triacylbenzenes (cochlospermines A 
and B) (Solon et al., 2012). Cochlospermum angolensis hydromethanolic extract 
revealed high levels of methyl ellagic acid and its derivatives with methyl ellagic acid 
pentoside isomer as the major compound, and the aqueous extract showed high amounts 
of ellagic acid and its derivatives (Ferreres et al., 2013). 
Nevertheless, scarce studies have been carried out regarding the phenolic composition 
and antimicrobial activity of different formulations of this plant. In the present work, 
infusion, pills and syrup of C. angolensis were characterized by HPLC-DAD-ESI/MS 
regarding phenolic composition, and evaluated by their in vitro antimicrobial activity 
against clinical isolates of multiresistant bacteria (Escherichia coli, Escherichia coli 
spectrum extended producer of β-lactamases (ESBL), Proteus mirabilis, methicillin-
resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa) obtained in the 
Hospital Center of Trás-os-Montes and Alto Douro (CHTMAD, Chaves, Portugal). 
 
2. Material and methods 
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2.1. Samples  
Cochlospermum angolensis Welw. (borututu) was obtained from an herbalist shop in 
Bragança (Portugal), as dry material for infusion preparation (bark), pills (containing 
500 mg of borututu roots, diluent -microcrystalline cellulose-, anti-agglomerating - 
dibasic calcium phosphate anhydrous and silicium dioxide-, and lubrificant -magnesium 
stearate-) and a syrup (containing 10% of borututu roots, acidity regulator -citric acid-, 
preservatives -potassium sorbate, sodium benzoate and propyl gallate-, and sweeteners -
aspartame, sodium cyclamate and saccharin).	  	  
 
2.2. Standards and reagents 
HPLC-grade acetonitrile was obtained from Merck KgaA (Darmstadt, Germany). 
Formic acid was purchased from Prolabo (VWR International, Fontenay-sous-Bois, 
France). Phenolic standards were from Extrasynthèse (Genay, France). Water was 
treated in a Milli-Q water purification system (TGI Pure Water Systems, Greenville, 
SC, USA). Methanol was of analytical grade purity from Lab-Scan (Lisbon, Portugal). 
The culture media Mueller Hinton broth (MHB), Wilkins–Chalgren broth (WCB) and 
Columbia agar (CA) with 5% horse blood were obtained from Biomerieux (Marcy 
l’Etoile, France). The dye p-iodonitrotetrazolium chloride (INT) was purchased from 
Sigma-Aldrich (St Louis, MO, USA) to be used as microbial growth indicator. 
 
2.3. Characterization in phenolic compounds  
2.3.1. Extraction procedures 
The infusion was prepared by adding the sample (1 g) to 200 mL of boiling distilled 
water, left to stand at room temperature for 5 min, and then filtered under reduced 
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pressure; afterwards the obtained infusion was frozen and lyophilized (FreeZone 4.5, 
Labconco, Kansas City, MO, USA). 
The pills (1.5 g) were reduced to powder and submitted to hydromethanolic extraction 
by stirring with 25 mL of methanol:water (80:20 v/v, 25 ºC at 150 rpm) for 1 h and 
subsequently filtered through Whatman No. 4 paper. The residue was then extracted 
with an additional 25 mL of methanol:water (80:20 v/v) for another hour. The combined 
extracts were dried (Büchi R-210, Flawil, Switzerland) and purified using a C18 
SepPak® Vac 3 cc cartridge (Phenomenex), previously activated with methanol 
followed by water; sugars and more polar substances were removed by passing through 
10 mL of water and the purified samples were further eluted with 5 mL of methanol. 
The extract was concentrated under vacuum. 
 The syrup (5 mL) was submitted to a purification following the procedure described 
above and then concentrated under vacuum. 
 
2.3.2. Analysis of phenolic compounds 
The previously described extracts and infusions were dissolved in water:methanol 
(80:20, v/v) and water, respectively and analysed using a Hewlett-Packard 1100 
chromatograph (Hewlett-Packard 1100, Agilent Technologies, Santa Clara, CA, USA) 
with a quaternary pump and a diode array detector (DAD) coupled to an HP Chem 
Station (rev. A.05.04) data-processing station. A Waters Spherisorb S3 ODS-2 C18, 3 
µm (4.6 mm × 150 mm) column thermostatted at 35 °C was used. The solvents were: 
(A) 0.1% formic acid in water, and (B) acetonitrile. The elution gradient established was 
isocratic 15% for 5 min, 15% B to 20% B over 5 min, 20-25% B over 10 min, 25-35% 
B over 10 min, 35-50% for 10 min, and re-equilibration of the column, using a flow rate 
of 0.5 mL/min. Double online detection was carried out in the DAD using 280 nm and 
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370 nm as preferred wavelengths and in a mass spectrometer (MS) connected to the 
HPLC system via the DAD cell outlet. 
MS detection was performed in an API 3200 Qtrap (Applied Biosystems, Darmstadt, 
Germany) equipped with an ESI source and a triple quadrupole-ion trap mass analyzer 
that was controlled by the Analyst 5.1 software. Zero grade air served as the nebulizer 
gas (30 psi) and turbo gas for solvent drying (400 ºC, 40 psi). Nitrogen served as the 
curtain (20 psi) and collision gas (medium). The quadrupols were set at unit resolution. 
The ion spray voltage was set at -4500V in the negative mode. The MS detector was 
programmed for recording in two consecutive modes: enhanced MS (EMS) and 
enhanced product ion (EPI) analysis. EMS was employed to show full scan spectra, so 
as to obtain an overview of all of the ions in sample. Settings used were: declustering 
potential (DP) -450 V, entrance potential (EP) -6 V, collision energy (CE) -10V. EPI 
mode was performed in order to obtain the fragmentation pattern of the parent ion(s) in 
the previous scan using the following parameters: DP -50 V, EP -6 V, CE -25V, and 
collision energy spread (CES) 0 V. Spectra were recorded in negative ion mode between 
m/z 100 and 1500. 
The phenolic compounds were identified by comparing their retention time, UV-vis and 
mass spectra with those obtained from standard compounds, when available. Otherwise, 
compounds were tentatively identified comparing the obtained information with 
available data reported in the literature. For quantitative analysis, a calibration curve for 
each available phenolic standard was constructed based on the UV signal. For the 
identified phenolic compounds for which a commercial standard was not available, the 
quantification was performed through the calibration curve of other compound from the 
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same phenolic group. The results were expressed in µg per g of lyophilized infusion or 
extract. For each formulation, the analyses were carried out in triplicate.  
 
2.4. Evaluation of antimicrobial activity  
2.4.1. Samples preparation 
The lyophilized infusion was redissolved in distilled water (final concentration 1000 
mg/mL). The pills were reduced to powder and dissolved in distilled water (final 
concentration 150 mg/mL). The syrup was directly used (100 mg/mL, according with 
the label information).  
 
2.4.2. Microorganisms and culture media 
The microorganisms used to screen the antimicrobial activity were clinical isolates from 
patients hospitalized in various departments of the Hospital Center of Trás-os-Montes 
and Alto Douro. Four Gram-negative bacteria (Escherichia coli isolated from urine, 
Escherichia coli spectrum extended producer of β-lactamases (ESBL) isolated from 
blood culture, Proteus mirabilis isolated from wound exudates and Pseudomonas 
aeruginosa isolated from urine) and one Gram-positive bacterium (methicillin-resistant 
Staphylococcus aureus (MRSA) isolated from wound exudates) were used. All strains 
were identified using the MicroScan® panels automated methodology (Siemens, 
Camberley, UK). 
 
2.4.3. Antimicrobial activity assays 
Minimum inhibitory concentration (MIC) determinations were performed by the 
microdilution method and the rapid p-iodonitrotetrazolium chloride (INT) colorimetric 
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assay following the methodology previously described by the authors (Alves et al., 
2012). 
Initially, 50 µL of each extract (1000, 150 and 100 mg/mL for the infusion, the pills and 
the syrup, respectively) was diluted in 450 µL of MHB (final concentration of 100, 15 
and 10 mg/mL, respectively) and then, 200 µL of this extract solution was added in each 
well (96-well microplate).  Dilutions were carried out over the wells containing 100 µL 
of MHB and, afterwards, 10 µL of inoculum (1 ×108 cfu/mL) were added to all the 
wells. Two negative (one with MHB and the other with the extract) and one positive 
(with MHB and the inoculum) controls were prepared. The plates were incubated at 37 
°C, for 24 h, in an oven (Jouan, Berlin, Germany).  
The MIC’s of the samples were detected after adding INT (0.2 mg/mL, 40 µL) and 
incubating at 37 °C for 30 min. Viable microorganisms reduced the yellow dye to a pink 
color. MIC was defined as the lowest extract concentration that prevented this change 
and exhibited complete inhibition of bacterial growth. All the assays were carried out in 
triplicate. 
 
2.5. Statistical analysis 
The results are expressed as mean values ± standard deviation (SD). The differences 
between the total phenolic compounds in different samples were analyzed using one-
way analysis of variance (ANOVA) followed by Tukey’s honestly significant difference 
post hoc test with α = 0.05, coupled with Welch’s statistic. This treatment was carried 
out using SPSS v. 22.0 program.  
 
3. Results and Discussion 
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3.1. Phenolic compounds 
Table 1 presents the data obtained from HPLC-DAD-MS analysis (retention time, λmax 
in the visible region, mass spectral data) used for the identification and quantification of 
phenolic compounds in borututu formulations.  
Compounds 2 and 8 were positively identified as protocatechuic acid and ellagic acid, 
respectively, according to their retention, mass and UV-vis characteristics by 
comparison with commercial standards. Compound 1 showed a fragmentation pattern 
characteristic of a digalloyl hexoside, with a precursor ion at m/z 483 and product ions 
at m/z 313 [M-H-170]-, 331 [M-H-162]- and 169 [M-H-162-152]- from the losses of 
gallic acid and hexosyl and galloyl moieties, respectively. Compound 3 presented a 
pseudomolecular ion [M-H]- at m/z 453 releasing MS2 fragment ions at m/z 169 and 313 
associated to a galloyl moiety and a galloylglucose group, respectively. A compound 
with similar characteristics was reported in Rhus coriaria by Abu-Reidah et al. (2015) 
and identified as hydroxymethoxyphenyl-galloyl-hexoside, so that this identity was 
tentatively assigned to our peak. Compound 4 ([M-H]- at m/z 497) also yielded fragment 
ions at m/z 169 and 313, this latter from the loss of 184 mu indicated as characteristic of 
oleuropeic acid (Hasegawa et al., 2008); these mass features are coherent with the 
structure of eucaglobulin or globulusin B (Figure 1), previously reported in the leaves 
of Eucalyptus globulus (Hasegawa et al., 2008; Boulekbache-Makhlouf et al., 2013).  
Compound 5 was assigned as (epi)gallocatechin-O-gallate owing to its pseudomolecular 
ion ([M-H]- at m/z 457) and fragment ions at m/z 305 and 169, corresponding to the 
deprotonated ions of (epi)gallocatechin and gallic acid, respectively.  
Compounds 6, 9, 12 and 13 presented similar UV-vis and mass spectra characteristic of 
ellagic acid derivatives All of them produced a major MS2 fragment ion at m/z 315, 
from the loss of hexosyl (-162 mu, compound 6), pentosyl (-132 mu, 9 and 12) or 
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deoxyhexosyl moieties (-146 mu, 13), which can be interpreted as corresponding to 
deprotonated methyl ellagic acid; the second product ion at m/z 300 would derive from 
the further loss of a methyl group (-15 mu). Compound 7, with a molecular mass 14 mu 
lower than 9 and 12 and a fragment ion at m/z 301 (-132 mu, loss of a pentosyl moiety; 
ellagic acid) was assigned as ellagic acid pentoside. All these compounds, together with 
ellagic acid, have been previously reported as majority phenolics in hydromethanolic 
extracts obtained from the bark of C. angolensis (Ferreres et al., 2013).  
Compounds 10 and 11 were assigned as flavanone glycosides based on their UV-vis and 
mass spectra. Compound 10 ([M-H]- at m/z 433 and MS2 fragment ion [M-H-162]- at 
m/z 271) was tentatively identified as a naringenin-O-hexoside, whereas compound 11 
([M-H]- at m/z 609 and MS2 fragment at m/z 301 [M-H-308]-) could be associated to a 
hesperetin-O-rutinoside or hesperetin-O-neohesperidoside. As far as we are aware, these 
compounds have not been previously reported in C. angolensis. 
A compound  with a pseudomolecular ion [M-H]- at m/z 211 was present in the syrup 
and corresponded to propyl gallate added to the syrup as a preservative, as described in 
its label, which also explained its high levels (data not shown).   
Ellagic acids, methyl ellagic acids, eucaglobulin/globulusin and (epi)gallocatechin-O-
gallate were the common compounds found in all the different formulations. The 
highest concentration of phenolic compounds was found in the infusion extract (Table 
1). Protocatechuic acid was the most abundant compound although it was only present 
in infusions; (epi)gallocatechin-O-gallate was the main phenolic in pills and 
eucaglobulin/globulusin in the syrup. 	  
 
3.2. Antimicrobial activity 
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The results obtained in the screening of antimicrobial activity of the different 
formulations of borututu (dietary supplements) against the studied bacteria are shown in 
Table 2. The infusion extract revealed the highest antimicrobial activity, with lower 
MIC values and proved to be able to inhibit the growth of E. coli, E. coli ESBL, S. 
aureus and P. aeruginosa, with MIC values of 50, 6.2, 1.6 and 25 mg/mL, respectively. 
The effectiveness of this formulation against E. coli and S. aureus could be due to the 
presence of protocatechuic acid that revealed antimicrobial activity against E. coli (β-
lactamases positive) in a previous study, when isolated from Ficus ovata (Kuete et al., 
2009). Pills revealed activity against E. coli ESBL and S. aureus MRSA in 
concentrations of 15 and 1.9 mg/mL, respectively. Lastly, the syrup did not reveal 
antimicrobial activity at the studied concentration (10 mg/mL). None of the tested 
formulations inhibited P. mirabilis. As far as we know, there are no reports on the 
antimicrobial activity of pills or syrups containing C. angolensis. 
 
Overall, among the different formulations, the infusion and pills revealed the highest 
variety of phenolic compounds, with eleven compounds identified, which can possibly 
explain their higher antimicrobial activity when compared to the syrup. In this latter, 
eight phenolic compounds were detected, although in low concentration, which may 
explain its lack of antimicrobial activity. Considering the obtained results, C. angolensis 
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Table 1. Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, identification and 
quantification of phenolic compounds in infusion extracts, pills and syrup of Cochlospermum angolensis (mean ± SD). 












Infusion Pills Syrup 
1 5.8 276 483 331(41),313(25),169(30) Digalloyl glucoside 117±6 27±2 nd 
2 6.0 259, 296sh 153 109(100) Protocatechuic acid 1782±40 nd nd 
3 7.8 280 453 313(11),169(8) 
Hydroxymethoxyphenyl-galloyl-
hexoside 
245±4 76±1 nd 
4 15.4 282 497 313(31),169(25) Eucaglobulin/globulusin B 492±51 430±5 381±11 
5 17.6 270 457 305(5),169(10) (Epi)gallocatechin-O-gallate 1040±8 777±15 155±15 
6 18.7 254, 362sh 477 315(64),300(20) Methyl ellagic acid hexoside 172±8 72±1 tr 
7 19.2 248, 362sh 433 301(100) Ellagic acid pentoside 50±8 nd nd 
8 20.7 246, 364sh 301 284(10),245(3),185(4),173(5),157(3),145(6) Ellagic acid 216±17 tr tr 
9 21.8 250, 362sh 447 315(43),300(12) Methyl ellagic acid pentoside 159±1 55±1 tr 
10 22.3 284, 340sh 433 271(100) Naringenin-O-hexoside nd 653±32 nd 
11 22.9 282, 338sh 609 301(100) 
Hesperitin-O-rutinoside/	  hesperetin-
O-neohesperidoside 
nd 111±7 nd 
12 24.7 248, 366sh 447 315(54), 300(15) Methyl ellagic acid pentoside 343±20 181±3 55±4 
13 26.9 250, 360sh 461 315(95), 300(41) Methyl ellagic acid deoxyhexoside 111±7 238±2 tr 
     Total phenolic compounds 4726±7a 2618±58 b 590±30c 
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Table 2. Antimicrobial activity of infusion extract, pills and syrup of Cochlospermum 
angolensis against bacteria clinical isolates. 
MIC - Minimum inhibitory concentration; ESBL - spectrum extended producer of β-
lactamases; MRSA - methicillin-resistant Staphylococcus aureus. 





Escherichia coli 50 >15 >10 
Escherichia coli ESBL 6.2 15 >10 
Proteus mirabilis >100 >15 >10 
MRSA 1.6 1.9 >10 



























Figure 1. Chemical structures of eucaglobulin (A) and globulusin B (B). 
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